Finally, we tested the protective potential of two RAL resistant inactivated IN variants (IN_a was excluded due to genotoxic enzymatic activity, and IN_in, due to immunotoxicity) in a murine tumor model of HIV-1 infection based on the 4T1luc2 cells expressing IN variants. This evidence concerns the gene CD44 and neoplasm.